Psychotropic Medications in Children and Adolescents: The Hazards and Pitfalls Associated with Their Use

Instructor:  Jeff Cole, PharmD, RPh

Register Now

 

 

Jeff ColeDate: Thursday, March 14, 2019

Time:  7:00 – 9:00 p.m.

Location: Institute Classroom A 8820 Ladue Rd., 3rd Floor, St. Louis, MO 63124

This course is available via Distance Learning.  Details HERE.

Course Level: Intermediate

Fee: $60

This program, when attended in its entirety, is offered for: 2.0 Credit Hours

 

The use of psychotropic medications for the treatment of psychiatric conditions in childhood and adolescence has increased exponentially during the last three decades and oftentimes outside of the context of talk therapy.  Clinicians and parents are expressing increased concern about the effectiveness of these medications, the validity of the diagnoses used to justify the use of these medications, and the harmful adverse events associated with their use and overuse, including the effect of these medications on the developing brain. This seminar will address these concerns and describe when medications are necessary, when they are needed during the context of talk therapy, and when and how they can be an impediment to helping children and adolescents restore a progressive course of psychological development.

Objectives:

  1. Describe the advantages and disadvantages in the prescription of psychotropic medications during childhood and adolescence.
  2. Describe common adverse drug events associated with the use of psychotropic medications during childhood and adolescence.
  3. Describe when and/or if the use of psychotropic medications are useful when children and adolescents are not participating in psychoanalysis or psychotherapy.
  4. Describe how psychotropic medications will help facilitate the effectiveness of psychotherapy or psychoanalysis in children and adolescents.
  5. Describe when psychotropic medications are necessary in the treatment of children and adolescents.

 Click HERE for Continuing Education Credit details.